rs765435961
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001458.5(FLNC):c.4413A>T(p.Gln1471His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000452 in 1,613,588 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001458.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FLNC | ENST00000325888.13 | c.4413A>T | p.Gln1471His | missense_variant | Exon 25 of 48 | 1 | NM_001458.5 | ENSP00000327145.8 | ||
FLNC | ENST00000346177.6 | c.4413A>T | p.Gln1471His | missense_variant | Exon 25 of 47 | 1 | ENSP00000344002.6 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152172Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000442 AC: 11AN: 248982Hom.: 1 AF XY: 0.0000666 AC XY: 9AN XY: 135164
GnomAD4 exome AF: 0.0000472 AC: 69AN: 1461416Hom.: 0 Cov.: 38 AF XY: 0.0000509 AC XY: 37AN XY: 727008
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152172Hom.: 0 Cov.: 34 AF XY: 0.0000269 AC XY: 2AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Variant summary: FLNC c.4413A>T (p.Gln1471His) results in a non-conservative amino acid change located in the Filamin/ABP280 repeat domain (IPR017868) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4.4e-05 in 248982 control chromosomes, predominantly at a frequency of 9.7e-05 within the Non-Finnish European subpopulation in the gnomAD database, including 1 homozygotes. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 9-fold of the estimated maximal expected allele frequency for a pathogenic variant in FLNC causing Cardiomyopathy phenotype (1.1e-05). c.4413A>T has been reported in the literature in individuals affected with Cardiomyopathy (Chumakova_2023,vanderMeulen_2022), without strong evidence for causality. These report(s) do not provide unequivocal conclusions about association of the variant with Cardiomyopathy. Co-occurrences with other pathogenic variant(s) have been reported (MYBPC3 c.743_746del, p.Asp248Alafs*51), providing supporting evidence for a benign role (Chumakova_2023). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 38002985, 36178741). ClinVar contains an entry for this variant (Variation ID: 539450). Based on the evidence outlined above, the variant was classified as likely benign. -
This missense variant results in an amino acid substitution of glutamine with histidine at codon 1471 of the FLNC gene. The variant has an entry in ClinVar (539450) NM_001458.5 (FLNC): c.4413A>T (p.Gln1471His) and has occurred in GnomAD with a total MAF of 0.0037% and highest MAF of 0.0081% in the European population. This position is not conserved. In silico functional algorithms agreed, with PolyPhen calling it possibly damaging, and SIFT deleterious, but no functional studies were performed to confirm these predictions. The variant has not occurred in literature associated with disease. Considering that this is a rare variant, whose impact on the protein and association with disease are unknown, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Cardiovascular phenotype Uncertain:1
The p.Q1471H variant (also known as c.4413A>T), located in coding exon 25 of the FLNC gene, results from an A to T substitution at nucleotide position 4413. The glutamine at codon 1471 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26;CN239310:Dilated Cardiomyopathy, Dominant Uncertain:1
This sequence change replaces glutamine, which is neutral and polar, with histidine, which is basic and polar, at codon 1471 of the FLNC protein (p.Gln1471His). This variant is present in population databases (rs765435961, gnomAD 0.008%). This missense change has been observed in individual(s) with FLNC-related conditions (PMID: 36178741). ClinVar contains an entry for this variant (Variation ID: 539450). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on FLNC protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at